WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and manufacturing. The vaccine is produced by the Beijing-based pharmaceutical company Sinovac.
WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations
June 1, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022